This randomised clinical trial aims to study osteoporosis as a disease of accelerated
skeletal aging caused by the accumulation of senescent cells within the skeleton and
investigate the effects and safety of senolytics and antioxidant therapy on bone.
Phase:
Phase 2
Details
Lead Sponsor:
Odense University Hospital
Collaborators:
Novo Nordisk A/S Odense Patient Data Explorative Network